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MitophagyRhomboids constitute the most widespread and conserved family of intramembrane cleaving proteases. They
are key regulators of critical cellular processes in bacteria and animals, and are poised to play an equally im-
portant role also in plants. Among eukaryotes, a distinct subfamily of rhomboids, prototyped by the mamma-
lian mitochondrial protein Parl, ensures the maintenance of the structural and functional integrity of
mitochondria and plastids. Here, we discuss the studies that in the past decade have unveiled the role, regu-
lation, and structure of this unique group of rhomboid proteases. This article is part of a Special Issue entitled:
Protein Import and Quality Control in Mitochondria and Plastids.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Proteases are enzymes that catalyze the hydrolysis of the peptide
bond that links amino acids together in a protein; they participate in
proteins catabolism and act as regulators of nearly every biological
process [1]. Proteases are grouped in different catalytic types,
depending on the catalytic amino acid residue used to conduct the
nucleophilic attack on the peptide-bond of the substrate: aspartic,
cysteine, glutamic, metallo (His), asparagine, threonine, and serine
proteases. Due to the requirement of water for the proteolytic reac-
tion, proteases were generally thought to hydrolyze their substrates
in an aqueous environment. However, in 1997 Rawson and colleagues
reported the discovery of site-2 protease, the ﬁrst kind of protease ca-
pable of executing hydrolysis within the water-excluding environ-
ment of the phospholipid bilayer, which composes most of the
biological membranes [2]. Such unique type of proteases are termed
intramembrane-cleaving proteases, or I-CLiPs, and are structurally
characterized by having the catalytic site residues projecting in a cav-
ity that is buried within the lipid bilayer of the membrane in which
the I-CliP is embedded [3].
To date, most of the I-CliP substrates appear to be membrane pro-
teins; their cleavage typically occurs at or near the transmembraneImport and Quality Control in
n santé mentale de Québec,
ellegrini).
rights reserved.helix (TMH) that anchors the substrate to the lipid bilayer [4,5].
Thus, their proteolysis serves to either complete protein maturation,
or to release membrane-tethered domains, which are typically used
for signaling [6]. Over the past decade, these released moieties have
been shown to engage in intra- and inter-cellular communication,
mainly by acting as transcription factors or ligands of signaling factors
in a process that is termed regulated intramembrane proteolysis [7,8].
There are four known families of I-CliPs: site-2 protease, ﬁrst dis-
covered as a regulator of cholesterol biosynthesis [2,9]; presenilins/
gamma secretase, implicated in Notch signaling [10] and Alzheimer's
disease [11,12]; signal peptide peptidase [13,14]; and the rhomboids
[15].2. Rhomboids genes
The Rhomboid gene was ﬁrst discovered in Drosophila. Fly devel-
opmental studies classiﬁed it under the Spitz group of genes, which
includes Spitz, Star, Pointed, Rhomboid, Single-minded, and Sichel: mu-
tations in any of these cause similar pattern alterations in ventral ec-
todermal derivatives of the ﬂy embryo [16]. Because the names of
these genes described the phenotype of the mutant larval cuticle,
the mis-shaped, rhombus-like head skeleton of the mutant embryo
earned to the Rhomboid-1 gene its name.
Rhomboid genes are present in most of the sequenced bacterial, ar-
chaeal and eukaryotic genomes [17]. Most of the bacterial and archaeal
genomes have a single rhomboid gene. In contrast, eukaryotes show ex-
pansion of the rhomboid family,with 2members in yeast, 7 inDrosoph-
ila, 5 in humans and as many as 13 in Arabidopsis t. [18]. Phylogenetic
analysis revealed that eukaryotic rhomboids are split between two
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karyotic branches [17]. Theﬁrst subfamilywas designated the RHO sub-
family [17]; its prototype is the Drosophila developmental regulator
Rho-1 [15,19–21]. The second eukaryotic subfamily was designated
the PARL subfamily, and its prototype is the mammalian Parl protein
which encodes for a mitochondrial inner membrane protein (discussed
below) [17]. Whereas in plants the PARL family is considerably more
represented, in animals there has been a selective expansion only of
RHO family members; indeed, animal genomes typically contain only
one PARL gene [17].What evolutionary constraints have led, in animals,
to the selective expansion of the RHO subfamily and, possibly, to the se-
lected elimination of additionalmembers of the PARL subfamily, remain
unknown. Instead, the remarkable expansion of the PARL subfamily in
plants appears to be linked to the presence of plastids: major plant-
and algae-speciﬁc self-replicating organelles that are the site of photo-
synthetic ﬁxation of CO2 and are responsible for the exclusive manufac-
ture and storage of starch and lipids. Although plastids greatly differ by
their pigmentation, function, and ultrastructure, they are thought to
have originated fromendosymbiotic cyanobacteria [22]: such symbiosis
parallels the event that lead to the acquisition of mitochondria in eu-
karyotes, which required the acquisition of a PARL family member to
control inner membrane remodeling [18]. Thus, the expansion of the
PARL family in plants could reﬂect the need to coordinate the remodel-
ing and organization of the chloroplast thylakoid membrane, whose
structure and dynamics is more complex than that of themitochondrial
cristae.
Phylogenetic analysis also identiﬁed a subgroup of rhomboid genes
that express proteins lacking the catalytic residues: pseudoproteases
[17]. These genes, which are present in all sequenced metazoans and
are present only in metazoans, are termed iRhoms, for inactive rhom-
boids [23]. Unlikemost sequencedmetazoans, Drosophila has only a sin-
gle iRhom gene, rhomboid-5. The high degree of conservation of iRhoms
genes indicates that these pseudoproteases have been under evolution-
ary selection pressure, which in turn indicates that they possess a rele-
vant biological function. Recent studies have indeed shown a critical
role of iRhoms in regulating growth factor signaling through endoplas-
mic reticulum-associated protein degradation (ERAD) [24], and in the in-
nate immunity response [25,26]. Derlin-1, a prominent component of
the ERAD pathway [27], and iRhom2 [25,26] are the most recently char-
acterizedmembers of the iRhom group of pseudoproteases inmammals.
3. Rhomboids evolutionary origin
Phylogenetic analysis indicates that rhomboid family emerged in
some bacterial lineage and widely disseminated by horizontal gene
transfer (HGT) [17]. Both archaea and eukaryotes seem to have ac-
quired rhomboids on several independent occasions. In particular, at
least two HGT events seem to have contributed to the origin of eu-
karyotic rhomboids, one of them yielding the RHO subfamily and
the other one the PARL subfamily, with a possible additional HGT in
plants [17].
4. Rhomboids structure
Rhomboids are intramembrane-cleaving serine proteases. They
are among the most conserved family of polytopic membrane pro-
teins known to date and the most ancient type of I-CliP [17]. Prokary-
otic and eukaryotic rhomboid proteins share only 10–15% of sequence
identity in their catalytic domain (Fig. 1A); this is not surprising since
polytopic transmembrane proteins are, in general, not strongly con-
served. Rhomboid proteases from all kingdoms of life share the fact
of having the catalytic domain composed by six TMHs [17]. Phenom-
enal work in protein crystallography has determined the structure of
this domain in bacterial rhomboids: the overall shape is a compact
helical bundle comprised of six TMHs and a lateral protrusion that
connects TMH-1 and ‐2 [28–33]. Nearly the entire rhomboid domainappears to be immersed in the phospholipid bilayer; the lateral pro-
trusion is only partially immersed in the membrane and might, there-
fore, serve to properly position the protease [33–35]. The universally
conserved catalytic Ser residue, on TMH-4, lies submerged ~10Å from
the presumed plane of the membrane, making the site of catalysis
intramembrane.
The structures of the bacterial rhomboids have revealed that the
catalytic Ser and His residues in TMH-4 and TMH-6, respectively,
are spatially arranged in a manner akin to classical serine proteases.
In dyad-based serine proteases, the serine–histidine pair act together
to generate a nucleophile of sufﬁcient power to attack the carbonyl
group of a peptide bond [36]. However, several serine proteases use
a triad-based mechanism of catalysis [37]; here, a third catalytic res-
idue, typically Asp or Asn, plays an important, but not essential, role
in stabilizing the tetrahedral intermediate and the transition state
leading to it. The structures of the bacterial rhomboids have unequiv-
ocally shown the existence of a catalytic dyad; indeed, a third con-
served Asn residue, which was suspected to act as a third catalytic
residue, is too remote and geometrically not in position to contact
the catalytic His and form a triad [28–33]. However, recent studies
form our laboratory have shown that eukaryotic members of the
PARL family of mitochondrial rhomboid proteases, but not of the
RHO family, could use a strongly conserved Asp residue on TMH-5
(Fig. 1D) in a triad-based mechanism of catalysis (Fig. 1C) [38]. The
reason why a mitochondrial rhomboid would require a catalytic
triad to properly work could be linked to the unique biophysical envi-
ronment of the organelle. Bacterial rhomboid activity is highly sensi-
tive to the phospholipid composition of the membrane in which they
are embedded. Accordingly, the unique lipid composition of the inner
mitochondrial membrane, along with the large electrochemical and
pH gradient present inside the organelle, might have applied a selec-
tive evolutionary pressure that, ultimately, generated a form of the
rhomboid protease with a more efﬁcient mechanism of catalysis.
Unlike bacterial rhomboids, eukaryotic members of the RHO and
PARL families possess seven TMHs; of these, 6 TMHs constitute the
catalytic rhomboid domain. However, major structural differences
differentiate these two types of rhomboid proteases. RHO family
members, which are localized in the Golgi and plasma membrane,
have the 7th TMH added at the carboxy-terminus of the 6-TMH
rhomboid core; this topology is referred to as the “6+1” structure.
Instead, the domain architecture of the rhomboids of the PARL sub-
family, which in animals are exclusively found in the mitochondrion
and in plants are likely localized in the membranes of the plastids,
is characterized by having the 7th TMH added to the amino-
terminus of the 6-TMH rhomboid domain; this topology constitutes
the “1+6” structure [17,18]. The function of the seventh TMH, ter-
med TMH-A and TMH-B in PARL and RHO family members, respec-
tively (Fig. 2A), has not been established for any member of the
PARL or RHO family. However, it may play a role in determining the
correct topology and orientation of the protein in the membrane, in
substrates gating or, in PARL family members, to orient TMH-5 in a
way that allows the protease to use a catalytic triad [18,38] (Fig. 1C).
Structure–function studies of the mammalian Parl rhomboid do-
main shows a remarkable structural conservation of this fold with
that of the bacterial GlpG protein (Fig. 1B). However, differences
seem to exist. As mentioned above, our studies suggest that an Asp
residue on the TMH-5 of Parl (D319; Fig. 1D), which is not present
in bacterial and RHO rhomboids, could play a critical structural and
catalytic role. Indeed, replacing D319 with Asn, Glu, Ala, or Leu pro-
foundly disrupted Parl expression and activity. In bacteria, TMH-5 is
a highly dynamic helix [30,34]: a similar property in Parl could
allow D319 to be positioned in close proximity, and on the same
plane, of the catalytic H335 residue (Fig. 1C), thereby conferring to
Parl a triad-based mechanism of catalysis. This is a likely possibility:
mutations designed to assess whether TMH-5 may rotate to bring
D319 into the active site (Fig. 1C) support indeed this scenario [38].
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Fig. 1. (A) Sequence alignment of GlpG and Parl used to build homology models. GlpG is a bacterial rhomboid of known structure that served as a template for homology modeling
of Parl rhomboid domain (PROD). Transmembrane helices (TMHs) are shaded in gray. (B) Overall topology of PROD with TMHs depicted as cylinders. The catalytic S277 and H335
residues lie on TMH-4 and ‐6, respectively (depicted as sticks in this ﬁgure). (C) The PARL-speciﬁc D319 is critical for Parl expression and activity, and might serve as a catalytic
residue. In PROD models, D319 is pointed into the membrane bilayer. Note that a rotation of TMH-5 would bring this residue adjacent to H335, where it could serve as a third cat-
alytic residue. (D) Strict conservation of D319 on the TMH-5 of eukaryotic orthologs of Parl. Note that this residue is conserved only in PARL family members and not in RHO-family
members or in bacterial rhomboids.
Figures were reproduced from [38].
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with the extensive plasticity of the IMM as well as with the notion
that mitochondria cristae junctions depend upon Parl activity for
their assembly [39–41]. Thus, the bilayer composition and ﬂuidity
within and around cristae junctions could play a central role in the
intrinsic regulation of Parl catalytic activity through the dynamicmovement of TMH-5, consistent with ﬁndings that indicate the im-
portance of lipid composition in bacterial rhomboid activity regula-
tion [42–44].
iRhoms are also rhomboids, but they lack protease activity due to
the absence of key residues and/or domains. They reside in the ER and
are considerably larger than active rhomboids, with very long N-
374 D.V. Jeyaraju et al. / Biochimica et Biophysica Acta 1833 (2013) 371–380terminal domains preceding the membrane-integral domain and an
expanded and conserved L1 loop between TMH-1 and TMH-2
(240–270 amino acids compared with 32 amino acids for the bacteri-
al GlpG protein) [45]. However, exceptions to such topological orga-
nization exist (e.g. Derlin-1). Given the increasingly important role
that iRhoms play in cell biology and disease [25,26,46], their crystal-
lographic analysis will provide major insights on the structuralβ-cleavage
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γ-cleavage 
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Fig. 2. (A) Scheme showing the proteolytic processing of Parl that generates three
forms of the enzyme: MAMP, PACT and PROD. (B) β-cleavage of Parl induces mito-
chondrial fragmentation. Note that cells transfected with wild type Parl have fragmen-
ted mitochondria whereas cells transfected with β-cleavage resistant Parl mutant L79E
have elongated, rod like mitochondria.
Figures were reproduced from [38].determinants that differentiate the activity of these pseudoproteases
from that of true rhomboid proteases.
5. Mitochondrial rhomboids
Rhomboid proteases have been ascribed to regulate a broad range
of biological processes: initiating cell signaling in animals [20], facili-
tating bacterial quorum sensing in prokaryotes [47,48], dismantling
adhesion complexes of parasitic protozoa [49–51], regulate plastid
proteins translocation [52], and regulating mitochondrial homeosta-
sis [53,54]. Here, we will focus on the role of mitochondrial rhomboid
in regulating the biology of the organelle and on its rising impact on
human diseases.
6. Pcp1/Rbd1, the yeast mitochondrial rhomboid
The yeast Saccharomyces cerevisiae has two rhomboid genes:
Rbd1 and Rbd2. Of these, Rbd1 encodes a mitochondrial rhomboid
protease that, being associated to the processing of the cytochrome
c peroxidase protein (Ccp1p), was named Pcp1 (Uniprot P53259)
[55]. Pcp1/Rbd1 codes for a polypeptide of 346 amino acid residues
(38.8 kDa) that contains a MitoProt-predicted mitochondrial
targeting sequence (score: 0.99). Consistent with the 1+6 structure
that deﬁnes every PARL family member, the protein has a predicted
TMH (106PLGSMTILGLSLMAGIYFG124) appended at the N-terminus
of its 6-TMH rhomboid domain, which spans amino acids 143–331.
The protease is inserted in the inner mitochondrial membrane,
where it serves to cleave Ccp1p [55] and, perhaps more importantly,
the dynamin-related protein Mgm1 [53,56], a dynamin GTPase im-
plicated in mitochondria fusion. Additional substrates of Pcp1/Rbd1
might exist, but their identiﬁcation is hindered by the fact that the
phenotype of yeast lacking Pcp1/Rbd1 activity is heavily impacted
by the loss of Mgm1 processing. Genetic ablation of Pcp1/Rbd1 has
a profound effect on mitochondrial shape, which becomes fragmen-
ted [53]: this phenotype is similar to that of yeast strains lacking
other regulators of mitochondrial fusion [57–60]. However, although
it is clear that the mitochondrial rhomboid protease in yeast has a
critical role in regulating mitochondria fusion and cristaemorpholo-
gy through the cleavage of Mgm1 [61], in Pcp1/Rbd1−/− cells mito-
chondrial fusion per se is not ablated [62]. As a result of lacking
Mgm1 cleavage, however, Pcp1/Rbd1−/− yeast cells cannot grow
on non-fermentablemedium and have compromised ability tomain-
tain their mitochondrial DNA content [53,62,63]. Importantly, this
phenotype can be restored by expressing the mammalian ortholog
of Pcp1/Rbd1, Parl [53,63].
7. Rho-7, the ﬂy mitochondrial rhomboid
The protein encoded by the Drosophila Rhomboid-7 gene (Rho-7)
is a 351 amino acid long mitochondrial rhomboid protease with the
typical 1+6 structure of the PARL family (Uniprot A1Z8R8). Deletion
of Rho-7 transcriptional start site and of the ﬁrst 18 codons, which en-
code part of the predicted mitochondrial import peptide of the pro-
tein (Mitoprot score: 0.99), causes 90% of the ﬂies to die before
pupariation; however, most of the ﬂies that escape death die within
three days, during the process of emerging from the pupal case [64].
Few male and female ﬂies live, but the males are sterile. Further, the
surviving mutant ﬂies display a wing-position defect: in these ﬂies,
the wings hang down on either side of the abdomen, instead of
being positioned on top of the abdomen. As a result, these ﬂies are
unable to ﬂy, have extreme difﬁculty walking, and display erratic
twitching in their legs and head, which correlate to severe synaptic
defects. Contrary to what is observed in mammals [40], ablation of
the mitochondrial rhomboid gene in Drosophila does not sensitize
cells to death-inducing insults [64].
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served in Rho-7−/− mutants, but in wild-type ﬂies ectopic over-
expression of the protease is semi-lethal (86% die) [65]. The selective
over-expression of Rho-7 in the nervous system is also semilethal, al-
beit to a reduced extent (49%); under this condition, the surviving
ﬂies develop into adults but have a shortened life span. Also, nearly
30% of larvae with this genotype display loss of motor coordination;
the remaining moved signiﬁcantly less coordinated compared to con-
trol larvae. This phenotype is accompanied by severe mitochondria
aggregation, lower ATP levels (42% compared to wild-type ﬂies),
and an overall decreased number of organelles within nerves/axons
[65]. Consistent with these ﬁndings, and with the data from yeast, si-
lencing of Rho-7 in Drosophila S2 cells results in fragmented mito-
chondrial morphology. Further, electron microscopic examination of
myoﬁbrils of wings in ﬂies lacking Rho-7 activity shows mitochondria
of reduced size [64]. Together with the genetic interaction observed
between Rho-7 and Opa1-like fusion [64]. However, it should be
noted that the structure of the cristae in Rho-7−/− cells is far less
compromised than that observed in Pcp1/Rbd1−/− yeast cells; also,
that the phenotype of ﬂies lacking bona ﬁdemitochondria fusion pro-
teins does not resemble that of Rho-7−/− ﬂies. Thus, further
investigations are required to ﬁrmly establish a role of the
drosophila mitochondrial rhomboid protease Rho-7 in mitochondrial
membranes fusion.
Pioneering studies have made emerge a role of Rho-7 in mitochon-
dria quality control. Rho-7−/− ﬂies exhibit remarkable phenotypic
similarity with PINK1−/− and Parkin−/− ﬂies, two Parkinson's genes
implicated in autophagic elimination (mitophagy) of mitochondria
that have lost membrane potential [66–69]. Further, in Rho-7−/−
ﬂies, PINK1, which is typically imported and cleaved in the mitochon-
drion, is found almost exclusively in its full-length form, suggesting a
role of the rhomboid protease in this processing [68]. Consistent with
this ﬁnding, Rho-7 genetically interacts with drosophila homologs of
PINK1 and Parkin, in a pattern consistent with Rho-7 acting upstream
of PINK1 [68]. Since a role of the mammalian rhomboid protease Parl
in PINK1 cleavage has recently been established (see below), these
data indicate functional conservation of animal PARL family members
in mitochondria quality control. However, in this respect it should be
noted that, unlike ﬂies, mice lacking mitochondrial rhomboid protease
activity do not show embryonic lethality and synaptic defects [40].
Such phenotypic differences might reﬂect the possibility that mamma-
lian Parl and drosophila Rho-7 could have a different set of substrates
and/or mechanisms of regulation. Indeed, structural differences exist
between these two orthologous proteins: in insects, the N-terminal do-
main and the loop that connects the distal TMH of the protease (TMH-
A) to the TMH-1 of its rhomboid protease domain (Fig. 2A) are different
from those found in mammals [38]. However, in mammals and higher
vertebrates these two domains show considerable conservation, there-
by supporting the possibility that during vertebrate evolution the func-
tion of themitochondrial rhomboid proteasemight have been recruited
to regulate mitochondrial pathways and activities not present in the
fruit ﬂy.8. Parl, the mammalian mitochondrial rhomboid
Parl wasﬁrst identiﬁed in a yeast two-hybrid screening inwhich the
bait protein was PS2-C-cas, the C-terminal moiety of Alzheimer's
Presenilin-2 that is produced by caspase cleavage during apoptosis
[70,71]. PS2-C-cas includes part of the large hydrophilic loop and the
last 3 TMHs of PS2 (a.a. 330–448); it shares a high degree of
homology to the C-terminus of Alzheimer's Presenilin-1, it is highly
conserved in mammals, and has anti-apoptotic activity [71]. The name
Parl, therefore, is the acronym of Presenilin-associated Rhomboid-like
protein [72]. However, the interaction between Parl and the Presenilin
proteins is artifactual, possibly due to the highly hydrophobic natureof these two polytopic membrane proteins: thus, to date there is no ev-
idence linking in any way Parl to the Alzheimer's presenilins [18,40].
The human Parl protein (Uniprot: Q9H300) is a 379 amino acid-
long polypeptide containing seven transmembrane helices, orga-
nized in a “1+6 structure” (Fig. 2A). The ﬁrst, proximal TMH
(101PLFFTVGFTGCAFGSAAIWQ120) is termed TMH-A. The rhomboid
protease domain spans amino acids 178–353, and the 6 TMHs that
compose it are termed TMH-1, -2,-3,-4,-5, and ‐6, to allow an easy
comparison with the 6 TMHs that constitute the catalytic serine pro-
tease domain found in all other prokaryotic and eukaryotic rhom-
boids [18].
Parl is inserted in the inner membrane of the mitochondrion. In cell
transfection-based studies, over-expressed Parl-Flag (C-term) appears
to expose its N-terminus in the mitochondrial matrix and its tagged C-
terminus in the intermembrane space (IMS) [73]. This topology posi-
tions the catalytic site of the protease in the matrix. However, such ori-
entation is not in agreement with evidence indicating that products of
its cleavage are in the IMS, thereby warranting further investigations
on the topology of the protease in other model organisms.
Parl is the mammalian ortholog of the yeast mitochondrial rhom-
boid protease Pcp1, which regulates mitochondria fusion through
proteolytic processing of Mgm1 (discussed above). Expression of
Parl in yeast cells lacking Pcp1/Rbd1 activity rescues Mgm1 cleavage
and mitochondria fusion [63]. The mammalian homolog of Mgm1 is
Opa1, which participates in mitochondrial fusion in association with
Mfn1 [74], a dynamin-related GTPase of the outer mitochondrial
membrane. However, even though a small amount (4%) of Opa1 is
processed by Parl, the function of the rhomboid protease in mammals
does not appear to be that of promoting mitochondrial fusion per se
because the architecture and fusion rate of mitochondria in Parl−/−
MEFs is similar to that measured in wild-type cells [40].
Parl+/− mice do not show any obvious phenotype [40]. Instead,
Parl−/− mice develop normally until the 4th postnatal week, after
which they start displaying severe growth retardation, with loss of
muscle mass and postural defects. The animals die within 8 to
12 weeks by progressive cachexia, possibly aggravated by feeding
and breathing problems. These animals have atrophic thymus and
spleen, with at least 90% reduction in weight of these organs due to
systemic cell death. Consistent with this phenotype, cells lacking
Parl proteolytic activity have been shown to be more susceptible to
intrinsic pro-apoptotic stimuli; this sensitivity correlates with a re-
duced amount of a cleaved form of Opa1 that, ultimately, impacts
on the rate of cytochrome c release [40,41]. Whether in some cancer
cells Parl activity is upregulated is not known, although this may be
a mechanism tumor cells develop to acquire insensitivity to intrinsic
pro-apoptotic stimuli or resistance to anti-cancer drugs.
The role of Parl in apoptosis has been suggested to be mediated
through an additional pathway. Here, the congenital neutropenia
protein Hax1 (Uniprot O00165) [75,76] presents the serine protease
Omi/HtrA2 to Parl, to facilitate the generation of an active form of
Omi/HtrA2 that prevents the accumulation of active Bax on the mito-
chondrial outer-membrane, which is required for cytochrome c re-
lease to the cytosol [77]. However, this model has been contested
[78] and in contradiction to numerous reports that localize Hax1 on
the ER, as well as with a wealth of studies that assign to Hax1 a differ-
ent function and binding partners [79–81]. Therefore, to date the only
established role of Parl in apoptosis is that that is linked to the Opa1-
mediated mechanism of cristae remodeling.
9. Proteolytic regulation of Parl activity
The N-terminal domain of Parl (spanning amino acids 1–100) un-
dergoes two distinct processing, termed α- and β-cleavage [82]
(Fig. 2A). The α-cleavage (Fig. 3.1) occurs at position G52↓F53, it is
constitutive, and removes the mitochondria targeting sequence that
imports the protease in the IMM. This processing, which is likely
376 D.V. Jeyaraju et al. / Biochimica et Biophysica Acta 1833 (2013) 371–380executed by one of the proteases that typically import proteins in the
IMM and matrix, produces MAMP, a mature mitochondrial form of
Parl with rhomboid protease activity (Fig. 3.1).
The β-cleavage (Fig. 3.3) occurs 25 amino acids downstream of
the α-cleavage, at position S77↓A78. This processing of Parl produces
two moieties (Fig. 3.3). The ﬁrst is the short Pβ-peptide
(53FRKAPRKVEPRRSDPGTSGEAYKRS77) which, after being liberated
in the cytosol reaches the nucleus through its nuclear localization se-
quence (see underlined amino acids above) [82]. Here, the Pβ-
peptide activates mitochondria biogenesis via the expression of
PGC1β, SIRT1, NRF1, Opa1, Mfn1, and Mfn2 (Fig. 3.3 inset) [83]. The
actual target and mechanism of activity of the Pβ-peptide remain
unknown, but given its small size it might act as a ligand of nuclear
transcription factors that regulates the expression of these genes.
The second moiety produced by the β-cleavage of Parl is PACT, for
Parl C-terminal fragment. PACT spans amino acids 78–379 of Parl and
retains rhomboid protease activity. Its function is to fragment mito-
chondria, possibly through a block membranes fusion (Fig. 3.3 inset)
[84]. Indeed, whereas the ectopic expression ofwild-type of Parl is asso-
ciated to a massive fragmentation of themitochondrial network, that of
amutant form of Parl in which β-cleavage abolished (e.g. L79E) does not
impact on the morphological organization of the organelles (Fig. 2B).
Noteworthy, ablating the generation of a functional Pβ-peptide, but
not of PACT, still results inmassivemitochondrial fragmentation, there-
by indicating that PACT is the sole moiety generated by β-cleavage that
is mechanistically coupled to mitochondria fragmentation [73].
Arresting mitochondria fusion has far reaching consequences for
the cell [85]. It is not surprising, therefore, that the generation of
PACT is placed under tight control by sophisticated mechanisms of
regulation. First, β-cleavage requires a mechanism of proteolysis
that depends on Parl rhomboid activity supplied in trans: in trans-
fected cells, a catalytically dead Parl S277G mutant is not subjected
to β-cleavage unless wild-type Parl is co-expressed [82]. Converging
evidence suggest that this processing on Parl N-terminus might be di-
rectly executed by another molecule of Parl (Fig. 3.3), thereby imply-
ing that Parl N-terminus can access the IMM-immersed catalytic site.
Second, Parl β-cleavage is sensitive to amino acid substitutions. Like
many other proteins whose activity depends on proteolytic activation
(e.g. caspases), mutations in either residues P2, P1, P1′ or P2′ (R76E,
S77E, A78E and L79E) of the cleavage site abolish β-cleavage [82].
Third, a mutation on P1 of the β-cleavage site, S77N, abolishes β-
cleavage and is linked to non-familial cases of Parkinson's disease
[86]. Fourth, β-cleavage of Parl is blocked by phosphorylation of
three residues located in close proximity to the β-cleavage site. En-
dogenous and transfected Parl are phosphorylated at residues Ser65,
Thr69, and Ser70; phosphomimetic (Asp) substitutions at these
amino acids impair β-cleavage without, however, affecting Parl
rhomboid activity per se [73]. Thus, a still uncharacterized kinase/
phosphatase switch (Fig. 3.2) is likely to be an integral component
of the mechanism of regulation of Parl β-cleavage in vivo. Fifth, β-
cleavage occurs in a domain that is strictly conserved in placental
and marsupial mammals. This indicates that during the ~100 million
years of mammalian evolution the domain harboring the β-cleavage site
must have been subjected to strong purifying selection, which can only
be explained by functional constraints linked to its regulatory role [73].
Since β-cleavage blocks mitochondria fusion, mechanisms that re-
lease this block and restore steady-state mitochondrial dynamics
must exist. We have recently shown that the activity of PACT and,
possibly, that of MAMP, is eliminated by yet another cleavage event,
on the large loop that connects the TMH-A and TMH-1 of the protease
(Fig. 2A). This processing, termed γ-cleavage, disrupts the 1+6
structure that deﬁnes every mitochondrial rhomboid protease and
generates a form of Parl that appears to be catalytically inactive and
unstable (Fig. 3.4) [38]. In vitro studies suggest that the activation of
γ-cleavage is mechanistically coupled to that of β-cleavage and medi-
ated by the activity of a serine protease. The identity of this proteaseis not known but our data exclude a role of Parl and Omi/HtrA2 in this
process (our unpublished observations).
Why ismitochondria fusion arrest linked to the activation of themito-
chondrial biogenesis pathway mediated by the Pβ peptide [83]? Two
non-alternative scenarios can be hypothesized (Fig. 4). In the ﬁrst, the
block of membrane fusion may reﬂect an underlying defect in the meta-
bolic competence of the organelle in which Parl is cleaved. In such case,
therefore, the damage supported by the organelle would be “the signal”
that activates β-cleavage. As a result, by blocking its ability to fuse back
into healthy mitochondria this “compromised organelle” would become
“quarantined”, providing an opportunity for the cell to survey its respira-
tory competence and repair it. Should the damage suffered by this organ-
elle be too extensive, during this quarantine this mitochondrion would
eventually lose its electrochemical potential. At this point the depolarized
organelle would disorganize its cristae via the Oma1-mediated stress-
induced processing of Opa1 [87,88] and be eliminated by mitophagy via
the PINK1/Parkin pathway (see below) [89]. In this way, Parl β-cleavage
would simultaneously initiate new mitochondrial biogenesis through
the Pβ peptide [83], and clear the cell of “old” or metabolically unre-
sponsive or damaged mitochondria via PACT-mediated fusion arrest. In
the second scenario, the small mitochondria generated by β-cleavage
could serve as the platform on which “growth” of mitochondrial mass
via the known mitochondrial biogenesis pathways can occur (Fig. 4).
The role of β-cleavage in human diseases has now started to
emerge. As mentioned above, a mutation on the β-cleavage site that
abolishes the ability of Parl to be subjected to β-cleavage has been as-
sociated to two sporadic cases of Parkinsonism [86].
Further, there might be a link with type-2 diabetes (T2DM). Pa-
tients with this metabolic conditions and Pima Indians, a group of Na-
tive Americans with a genetic predisposition for T2DM, have less
mitochondrial mass and reduced Parl expression, a phenotype that
is consistent with reduced β-cleavage and Pβ peptide-mediated sig-
naling, which can activate the expression of a plethora of genes impli-
cated in regulating mitochondrial biogenesis and dynamics (PGC1β,
SIRT1, NRF1, Opa1, Mfn1, and Mfn2) [83].
What triggers β-cleavage remains to be determined, although in
HeLa cells a number of stimuli that are known to trigger mitochondria
fragmentation via ﬁssion activation do not induce β-cleavage of en-
dogenous or transfected Parl (our unpublished observations). How-
ever, in HEK293 cells, β-cleavage seems to be activated when cells
become highly or over conﬂuent. Our ongoing studies on a mouse
mutant deﬁcient in Parl β-cleavage will contribute to elucidate the
function of such an intricate mitochondrial processing event that im-
pacts on mitochondria biology and human health in a unique way.
10. Role of Parl in the PINK1 mitochondria quality control pathway
Parkinson's disease (PD) is one of the most common neurodegen-
erative disorders affecting aging populations and consists in the pro-
gressive loss of dopaminergic neurons in the substantia nigra [90].
Even though PD is a sporadic neurological disorder, familial forms of
the disease exist: in such cases, affected patients carry mutations in
one of the PARK genes. One of them is PINK1 [91,92], a gene that en-
codes a serine/threonine kinase that is found in the mitochondria and
cytosol. PINK1 serves to signal the presence of dysfunctional mito-
chondria. The mechanism centers around the mitochondria mem-
brane potential-dependent proteolysis of full-length PINK1 (63 kDa)
in a shorter 52 kDa form that is then eliminated. This processing of
PINK1 maintains low levels of PINK1 on healthy (polarized) mitochon-
dria. Loss of membrane potential inhibits PINK1 cleavage, leading to its
accumulation on the cytosolic side of the outer mitochondrial mem-
brane; this event, in turn, recruits the E3 ubiquitin ligase Parkin protein
on the cytosolic face of the mitochondrion, which presides the
mitophagic elimination of the damaged (depolarized) organelle via
the ubiquitination of Mfn1 and other OMM proteins [93–95]. Recent
studies have shown that the 52 kDa form of PINK1 requires, and is
1IMM
α-cleavage of PARL during import generates MAMP
catalytic site
MAMPPARL
phosphorylated  MAMPkinase
2
β-cleavage of unphosphorylated MAMP, 
possibly by another MAMP, 
generates PACT and the Pβ-peptide
(phosphorylation at residues 
S65, T69, and S70 blocks β-cleavage)  
3
Pβ
peptide
PACT
4
PACT activity is eliminated via γ-cleavage, on the IMS loop 
P-β peptide
nucleus
The Pβ-peptide is exported in 
the cytosol and targeted to 
the nucleus; 
PACT fragments the mitochondrion
MAMP is phosphorylated at residues S65, T69, S70
PACT
Fig. 3. Scheme showing the cascade of events regulating Parl activity in the mitochondrion. 1) Import and insertion of Parl in the inner (IMM) mitochondrial membrane. α-cleavage at
amino acid 52↓53 removes the mitochondrial targeting sequence from Parl N-terminus [82]; the α-cleaved form of Parl is called MAMP, for mature mitochondrial Parl [82].
2) MAMP N-terminus becomes constitutively phosphorylated by a still uncharacterized kinase (in yellow) at Ser-65, Thr-69, and Ser-70 [73]; note that the phosphorylation
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(in pink) is cleaved at amino acid 77↓78, most likely by another form of Parl (MAMP/PACT), in trans (in blue) [82]. β-cleavage generates two moieties: the N-terminal Pβ pep-
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exported to the nucleus [82] and fragments the mitochondrion [73]. 4) PACT activity is eliminated via γ-cleavage, on the loop-A of the protease [38].
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Parl [86,89,96,97].
Another line of evidence links Parl to PD. A recent study has asso-
ciated a missense mutation in Parl, S77N, to two cases of sporadic par-
kinsonism [86]. This variant impairs the β-cleavage (see above) and,
consequently the generation of PACT and of the Pβ-peptide, without,
however, affecting Parl rhomboid protease activity per se [73,82,86]
(Figs. 3 and 4). Interestingly, similar to a catalytically dead Parl
S277G mutant, the S77N mutation displays inefﬁcient Parkin recruit-
ment to mitochondria that have lost membrane potential. Hence,
the S77N mutation seems to impact on mitochondria quality control
independent of PINK1 processing, for which Parl rhomboid activityis needed. Future studies will likely clarify the implication of Parl β-
cleavage in parkinsonism and mitochondria quality control.
11. Rhomboids substrate recognition and speciﬁcity
Typically, proteases use residues ﬂanking the cleavage site of the
substrate to recognize the scissile bond to cleave. This paradigm
seems to apply also to bacterial and RHO rhomboids (but not to other
types of I-CLiPs); here, only amino acids harboring a small side chain
are permitted at the P1 position (A,G,C,S), whereas large, hydrophobic
side chains are required at P4 position (I,M,YF,W,LV) and preferred at
the P2′ (F,IM,V,A,CL,T,W). Instead, some residues are not tolerated at
“Quarantine” to allow for
mitochondrial quality control check
Mitochondria eliminated
by mitophagy
β-cleavage of Mature mitochondrial
Parl (MAMP) is activated as a 
result of a metabolic instruction 
or of a mitochondrial damage signal. 
This generates PACT and the Pβ-peptide 
The Pβ-peptide is 
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where it activates Sirtuin-1
PACT blocks fusion and 
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Next 24 hours:
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completed
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Fig. 4.Models explaining the possible function of Parl β-cleavage, which couples mitochondria dynamics [73] to mitochondria biogenesis [83] via the generation of PACT and of the
nuclear Pβ peptide, respectively.
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(GYHKRDENQP) [5,98]. For mitochondrial rhomboids less is known.
However, the β-cleavage site of Parl, whose cleavage is strictly depen-
dent of Parl activity supplied in trans [82], is consistent with these re-
quirements (AP5YP4KP3RP2SP1↓AP1′LP2′), thereby further supporting
the possibility that this cleavage is indeed directly executed by Parl.
As for the cleavage site of PINK1 and Mgm1, which depend onmitochondrial rhomboid activity, the residue at position P1 (for
Mgm1) and P2′ (for PINK1) do not seem to ﬁt with this consensus se-
quence (Mgm1 — site1: GP5TP4VP3PP2TP1↓AP1′TP2′; Mgm1 — site
2: VP5, PP4TP3AP2TP1↓LP1′IP2′; PINK1: AP5VP4FP3LP2AP1↓FP1′GP2′;)
[53,96].
Current evidence [5,99] suggest a model where the recruitment of a
rhomboid substrate occurs in two phases. The ﬁrst step involves the
379D.V. Jeyaraju et al. / Biochimica et Biophysica Acta 1833 (2013) 371–380interaction of the substrate's TMH to a membrane-immersed rhomboid
exosite. The second step consists of the recognition of residues
encompassing the cleavage site of the substrate, and their docking
into the active site cleft of the protease. Accordingly, a substrate's cleav-
age sites can reside considerably distant from its TMH, as it is the case
for Parl β-cleavage site, which is located 24 amino acid residues away
from TMH-A. It is tempting to speculate that TMH-A, in PARL family
members, and TMH-B, in RHO family members, could participate to
the formation of the exosite(s) that govern the substrate speciﬁcity of
the eukaryotic rhomboids. This possibility is supported by the
fact that, in the mammalian mitochondrial rhomboid Parl protein,
TMH-A harbors a conserved GxxxG TMHs-dimerization motif [100]
(101PLFFTVGFTGCAFGSAAIW118).
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